A majority of HNSCC patients exhibit marked overexpression of Bcl-XL [3] which has been shown to correlate with resistance to chemotherapy and radiotherapy and with poor clinical prognosis [4, 5]. This evidence concerns the gene BCL2L1 and head and neck squamous cell carcinoma.